Variantyx: Funding, Investors & Team (Oct 2026)
Based on clinical whole genome sequencing (WGS) and using a single patient sample, Variantyx's Genomic Unity® test identifies and reports all major variant types including small sequence changes, structural variants, mitochondrial variants and short tandem repeat expansions. This comprehensive test test eliminates the need for traditional step-wise, reiterative genetic testing.
Variantyx has raised $124M across 6 funding rounds on record, the most recent an undisclosed round of $36.0M announced in Apr 2024.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Variantyx Company Profile and Key Stats
Latest funding round on record: Apr 2024.
Variantyx Funding Rounds
1 of 6 rounds was announced without a disclosed amount and is excluded from the total.
Variantyx raised $20.0M in a Series C announced in Mar 2021.
8 months later, a Series C of $6.0M was announced in Nov 2021.
3 months later, a Series C of $41.5M was announced in Feb 2022.
8 months later, a Debt Financing of $20.0M was announced in Oct 2022.
1 years later, an undisclosed round was announced in Oct 2023 with no disclosed amount.
6 months later, an undisclosed round of $36.0M was announced in Apr 2024.
Variantyx Founders and Leadership Team
Contact details for the Variantyx team: 2 of 2 have an email address on file.
Start 14-day free trial →Variantyx Funding Compared to Other Biotechnology Startups
Variantyx's latest round of $36.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Variantyx in Biotechnology and Framingham
Companies Similar to Variantyx
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Variantyx Funding FAQs
What does Variantyx do?
Based on clinical whole genome sequencing (WGS) and using a single patient sample, Variantyx's Genomic Unity® test identifies and reports all major variant types including small sequence changes, structural variants, mitochondrial variants and short tandem repeat expansions. This comprehensive test test eliminates the need for traditional step-wise, reiterative genetic testing.
How much funding has Variantyx raised?
Variantyx has raised $124M across 6 rounds on record. The most recent is an undisclosed round of $36.0M announced in Apr 2024.
When did Variantyx last raise funding?
Variantyx's most recent funding round on record is an undisclosed round of $36.0M, announced in Apr 2024.
Who is the CEO of Variantyx?
Haim Neerman is listed as CEO at Variantyx.
Where is Variantyx headquartered?
Variantyx is based in Framingham, Massachusetts, United States.
How many employees does Variantyx have?
Variantyx is in the 101-250 employee band.
How does Variantyx's funding compare to other Biotechnology startups?
Variantyx's latest round of $36.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Variantyx Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Variantyx is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.